Homozygous APOE3-Christchurch (R136S) mutation protects a presenilin 1 (PSEN1) mutation carrier from developing Alzheimer’s disease until her seventies.
References
Huang, Y. & Mucke, L. Cell 148, 1204–1222 (2012).
Quiroz, Y. T. et al. JAMA Neurol. 75, 548–556 (2018).
Acosta-Baena, N. et al. Lancet Neurol. 10, 213–220 (2011).
Arboleda-Velasquez, J. F. et al. Nat. Med. https://doi.org/10.1038/s41591-019-0611-3 (2019).
Mahley, R. W., Huang, Y. & Rall, S. C. Jr. J. Lipid Res. 40, 1933–1949 (1999).
Rauch, J. N. et al. Sci. Rep. 8, 6382 (2018).
Corder, E. H. et al. Science 261, 921–923 (1993).
Liu, C. C., Kanekiyo, T., Xu, H. & Bu, G. Nat. Rev. Neurol. 9, 106–118 (2013).
Wang, C. et al. Nat. Med. 24, 647–657 (2018).
Najm, R., Jones, E. A. & Huang, Y. Mol. Neurodegener. 14, 24 (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Y. H. is a cofounder and scientific advisory board member of E-Scape Bio, Inc. and GABAeron, Inc. The other authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Zalocusky, K.A., Nelson, M.R. & Huang, Y. An Alzheimer’s-disease-protective APOE mutation. Nat Med 25, 1648–1649 (2019). https://doi.org/10.1038/s41591-019-0634-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-019-0634-9
- Springer Nature America, Inc.
This article is cited by
-
Genetics of Alzheimer’s disease: an East Asian perspective
Journal of Human Genetics (2023)
-
The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammation
Nature Neuroscience (2023)
-
Dissecting the clinical heterogeneity of early-onset Alzheimer’s disease
Molecular Psychiatry (2022)